Business Insights: Page 4

Guardant and Illumina resolve lawsuit, reach agreement

In a statement, Guardant said the “three-year agreement includes a joint request to dismiss with prejudice the pending litigation between the companies.” The request to dismiss includes “any allegations related to the subject intellectual property.”

August 7, 2023

Labcorp targets growth at new unit after fixing non-human primate supply issues

While the supply disruption continued to hold back growth in the second quarter, Labcorp told investors it has resolved the problem and there will be no further impact over the second half of the year.

August 7, 2023

NIH names Jeanne Marrazzo to fill NIAID post vacated by Anthony Fauci

Marrazzo currently works as director of the Division of Infectious Diseases at the University of Alabama at Birmingham and is expected to take up her position as the director of the NIAID in the fall.

August 3, 2023

OIG audit shows some IHS COVID-19 funds misused, recommendations issued

The OIG determined that the funds were misused – or not used before the funds expired – because the IHS did not provide clear guidance or oversight to the programs for the use of the funds or the accounting and tracking of these funds.

August 2, 2023

Roche’s diagnostic base business growth unable to offset falling COVID-19 sales in Q2

Demand for tests remained high in the first half of last year with the Omicron variant but has since fallen, taking Roche’s revenues down with it. In the first quarter, Roche’s diagnostics sales fell 28% despite 4% growth in the base business.

August 3, 2023

FDA awards EUA to Alphadera Labs’ COVID-19 test

Alphadera Labs received the EUA after evaluating its test on 60 clinical nasopharyngeal swabs specimens. ALPHADx provided the same results as a “highly sensitive” FDA-authorized molecular SARS-CoV-2 test.

August 2, 2023

New Day Diagnostics inks $12M deal to buy Epigenomics’ cancer technology

Epigenomics has agreed to sell “substantially all” of its assets to New Day Diagnostics, a developer of tests for the early detection and monitoring of disease that merged with EDP Biotech earlier this month.

July 31, 2023

Quest Diagnostics teams up with Envision Science on prostate cancer biomarkers

The test aims to improve the accuracy of grading biopsies for prostate cancer, which is one of the most prevalent and deadly cancers affecting men.

July 27, 2023

Co-Diagnostics awarded over $2M from Bill & Melinda Gates Foundation for TB and HPV tests

Dwight Egan, CEO of Co-Diagnostics, said the grants would help support the worldwide effort to prevent the spread of both TB and HPV in countries where they have been endemic killers for generations.

July 26, 2023

Illumina inks deal to sell Pillar Biosciences’ cancer assays

Pillar, which has partnerships with Beckman Coulter Life Sciences and Labcorp, designed its NSCLC and CRC panel to run on the Illumina MiSeq Dx instrument. The instrument is a next-generation sequencing (NGS) platform for in vitro diagnostic testing.

July 26, 2023

Vector Laboratories buys Quanta Bio for polyethylene glycol technology

Single molecular weight, discrete-length PEG chains such as Quanta’s dPEG products can simplify peptide analysis compared to other products that contain a range of PEG chain lengths and molecular weights.

July 24, 2023

FDA starts one-year pilot program to tackle risks of lab developed oncology tests

The goal is to provide laboratories with information to support development of LDTs for specific cancer biomarkers, to facilitate “better and more consistent” testing and, by extension, “better drug selection and improved care for patients with cancer."

July 21, 2023

Previous Page

Page 4 of 163

Next Page